22 Jan 2021
// GLOBENEWSWIRE
http://www.globenewswire.com/news-release/2021/01/22/2162627/0/en/ONO-Receives-a-Manufacturing-and-Marketing-Approval-of-Adlumiz-Anamorelin-a-Ghrelin-Receptor-Agonist-for-the-Treatment-of-Cancer-Cachexia-in-Japan.html
LOOKING FOR A SUPPLIER?